SciBase Holding AB (publ) (SCIB.ST)
SEK 0.37
(-6.03%)
SEK 0.37
(-6.03%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 4.17 Million SEK | -19.82% |
| 2022 | 5.21 Million SEK | 1364.04% |
| 2021 | 356 Thousand SEK | -79.33% |
| 2020 | 1.72 Million SEK | -50.81% |
| 2019 | 3.5 Million SEK | 0.0% |
| 2018 | - SEK | 0.0% |
| 2017 | - SEK | 0.0% |
| 2016 | - SEK | 0.0% |
| 2015 | - SEK | 0.0% |
| 2014 | - SEK | 0.0% |
| 2013 | - SEK | 0.0% |
| 2012 | - SEK | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | - SEK | 0.0% |
| 2024 Q1 | 3.51 Million SEK | 0.0% |
| 2023 Q4 | 4.17 Million SEK | -9.74% |
| 2023 Q1 | 4.56 Million SEK | -12.34% |
| 2023 Q3 | 4.63 Million SEK | 18.08% |
| 2023 FY | 4.17 Million SEK | -19.82% |
| 2023 Q2 | 3.92 Million SEK | -14.18% |
| 2022 Q1 | 1.88 Million SEK | 428.93% |
| 2022 Q3 | 650 Thousand SEK | -48.78% |
| 2022 FY | 5.21 Million SEK | 1364.04% |
| 2022 Q4 | 5.21 Million SEK | 701.85% |
| 2022 Q2 | 1.26 Million SEK | -32.61% |
| 2021 Q2 | 1.52 Million SEK | 0.0% |
| 2021 Q4 | 356 Thousand SEK | -62.37% |
| 2021 Q3 | 946 Thousand SEK | -38.09% |
| 2021 Q1 | - SEK | -100.0% |
| 2021 FY | 356 Thousand SEK | -79.33% |
| 2020 Q3 | 2.15 Million SEK | -16.65% |
| 2020 Q4 | 1.72 Million SEK | -20.2% |
| 2020 Q1 | 3.01 Million SEK | -13.85% |
| 2020 FY | 1.72 Million SEK | -50.81% |
| 2020 Q2 | 2.58 Million SEK | -14.16% |
| 2019 Q2 | - SEK | 0.0% |
| 2019 FY | 3.5 Million SEK | 0.0% |
| 2019 Q4 | 3.5 Million SEK | 0.0% |
| 2019 Q3 | - SEK | 0.0% |
| 2019 Q1 | - SEK | 0.0% |
| 2018 FY | - SEK | 0.0% |
| 2018 Q1 | - SEK | 0.0% |
| 2018 Q2 | - SEK | 0.0% |
| 2018 Q3 | - SEK | 0.0% |
| 2018 Q4 | - SEK | 0.0% |
| 2017 Q4 | - SEK | 0.0% |
| 2017 FY | - SEK | 0.0% |
| 2017 Q3 | - SEK | 0.0% |
| 2017 Q2 | - SEK | 0.0% |
| 2017 Q1 | - SEK | 0.0% |
| 2016 Q1 | - SEK | 0.0% |
| 2016 Q3 | - SEK | 0.0% |
| 2016 Q2 | - SEK | 0.0% |
| 2016 Q4 | - SEK | 0.0% |
| 2016 FY | - SEK | 0.0% |
| 2015 FY | - SEK | 0.0% |
| 2015 Q2 | - SEK | 0.0% |
| 2015 Q3 | - SEK | 0.0% |
| 2015 Q4 | - SEK | 0.0% |
| 2015 Q1 | - SEK | 0.0% |
| 2014 FY | - SEK | 0.0% |
| 2014 Q4 | - SEK | 0.0% |
| 2014 Q1 | - SEK | 0.0% |
| 2013 FY | - SEK | 0.0% |
| 2012 FY | - SEK | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Acarix AB (publ) | - SEK | -Infinity% |
| ADDvise Group AB (publ) | 1.45 Billion SEK | 99.713% |
| ADDvise Group AB (publ) | 1.45 Billion SEK | 99.713% |
| Arcoma AB | 1.92 Million SEK | -116.866% |
| Bactiguard Holding AB (publ) | 42.3 Million SEK | 90.122% |
| BICO Group AB (publ) | 1.75 Billion SEK | 99.762% |
| Boule Diagnostics AB (publ) | 57.7 Million SEK | 92.757% |
| CellaVision AB (publ) | 28.66 Million SEK | 85.421% |
| Clinical Laserthermia Systems AB (publ) | 223 Thousand SEK | -1773.991% |
| Chordate Medical Holding AB (publ) | - SEK | -Infinity% |
| C-Rad AB (publ) | 1.75 Million SEK | -138.391% |
| Duearity AB (publ) | 2.94 Million SEK | -42.143% |
| Dignitana AB (publ) | 6.07 Million SEK | 31.233% |
| Episurf Medical AB (publ) | 2.3 Million SEK | -81.696% |
| Getinge AB (publ) | 3.9 Billion SEK | 99.893% |
| Scandinavian Real Heart AB (Publ) | 6.35 Million SEK | 34.219% |
| Iconovo AB (publ) | 4.9 Million SEK | 14.834% |
| Integrum AB (publ) | 4.84 Million SEK | 13.738% |
| Luxbright AB (publ) | 206.02 Thousand SEK | -1928.404% |
| Mentice AB (publ) | 2.14 Million SEK | -94.916% |
| OssDsign AB (publ) | 214 Thousand SEK | -1852.804% |
| Paxman AB (publ) | 2.53 Million SEK | -65.047% |
| Promimic AB (publ) | - SEK | -Infinity% |
| Qlife Holding AB (publ) | 3 Million SEK | -39.115% |
| ScandiDos AB (publ) | - SEK | -Infinity% |
| Sectra AB (publ) | 19.2 Million SEK | 78.239% |
| Sedana Medical AB (publ) | 1.01 Million SEK | -312.945% |
| Senzime AB (publ) | 8.57 Million SEK | 51.282% |
| SpectraCure AB (publ) | 4.39 Million SEK | 4.958% |
| Stille AB | 38.06 Million SEK | 89.022% |
| Vitrolife AB (publ) | 1.87 Billion SEK | 99.777% |
| Xvivo Perfusion AB (publ) | 21.16 Million SEK | 80.259% |